Perspectives

Perspectives

Commentary and highlights from contributors and readers

Biosimilars in Hematology: A Work in Progress

Recently, I was reviewing editorial content for ASH Clinical News, when I came across an article covering the U.S. Food and Drug Administration’s (FDA’s)...

#SHEmatology and #WOMANcology: Encouraging Women to Explore Careers and Leadership in Hematology and Oncology

Over the past 50 years, women in medicine have gained greater representation, with each generation of trainees moving closer to gender parity. The number...

My Fair MDs: Encouraging Doctors to Speak Plainly

“An Englishman's way of speaking absolutely classifies him. The moment he talks he makes some other Englishman despise him. One common language I'm afraid we'll never...

How to Treat HELLP Syndrome

Here’s how readers responded to a You Make the Call question about treatment of HELLP (hemolysis, elevated liver enzymes, low platelet count) syndrome. Disclaimer: ASH...

How to Treat Ph-negative Precursor B-cell ALL and Ischemic Cardiomyopathy

Here’s how readers responded to a You Make the Call question about the management of Ph-negative ALL in a patient with ischemic cardiomyopathy. Disclaimer: ASH...

How to Treat Anemia in a Patient Who Refuses Transfusions for Religious Reasons

Here’s how readers responded to a You Make the Call question about a Jehovah's Witness patient with stage IV uterine cancer, a uterine abscess,...

Draining the Email Swamp

On a typical weekday, I receive 200 emails and send 40. Unless you, dear reader, are the taciturn Seattle hematologist who hasn’t responded to...

Recommendations from My Bookshelf: A Bloody Mess

Imagine that you’re young, brilliant, charismatic, and you have a compelling vision for a bold new idea that could revolutionize health care: scores of...

How would you treat a patient with autoimmune hepatitis, grade 4 cirrhosis, and declining...

Here’s how readers responded to a You Make the Call question about a 22-year-old patient presenting with epistaxis, a platelet count of zero, abnormal...

My Twitter Journey

My journey to Twitter was not my idea. A few years ago, the chairman of the Cleveland Clinic Taussig Cancer Institute, Brian Bolwell, MD...
Advertisement

Current Issue

March 2019, Volume 5, Issue 4

This issue features a look at the misconceptions about travel-associated blood clots, the treatment of young patients with myeloma, and more.